JP2012511028A5 - - Google Patents

Download PDF

Info

Publication number
JP2012511028A5
JP2012511028A5 JP2011539772A JP2011539772A JP2012511028A5 JP 2012511028 A5 JP2012511028 A5 JP 2012511028A5 JP 2011539772 A JP2011539772 A JP 2011539772A JP 2011539772 A JP2011539772 A JP 2011539772A JP 2012511028 A5 JP2012511028 A5 JP 2012511028A5
Authority
JP
Japan
Prior art keywords
compound according
compound
pharmaceutical composition
diabetes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011539772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012511028A (ja
JP5666464B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/066941 external-priority patent/WO2010068581A1/en
Publication of JP2012511028A publication Critical patent/JP2012511028A/ja
Publication of JP2012511028A5 publication Critical patent/JP2012511028A5/ja
Application granted granted Critical
Publication of JP5666464B2 publication Critical patent/JP5666464B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011539772A 2008-12-08 2009-12-07 新規化合物 Expired - Fee Related JP5666464B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12059608P 2008-12-08 2008-12-08
US61/120,596 2008-12-08
PCT/US2009/066941 WO2010068581A1 (en) 2008-12-08 2009-12-07 Novel compounds

Publications (3)

Publication Number Publication Date
JP2012511028A JP2012511028A (ja) 2012-05-17
JP2012511028A5 true JP2012511028A5 (https=) 2013-01-31
JP5666464B2 JP5666464B2 (ja) 2015-02-12

Family

ID=42243044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011539772A Expired - Fee Related JP5666464B2 (ja) 2008-12-08 2009-12-07 新規化合物

Country Status (22)

Country Link
US (3) US9163024B2 (https=)
EP (1) EP2370440B1 (https=)
JP (1) JP5666464B2 (https=)
KR (1) KR101743783B1 (https=)
CN (1) CN102245606B (https=)
AU (1) AU2009324811B2 (https=)
BR (1) BRPI0922134A2 (https=)
CA (1) CA2746316C (https=)
CY (1) CY1116032T1 (https=)
DK (1) DK2370440T3 (https=)
EA (1) EA020037B1 (https=)
ES (1) ES2527354T3 (https=)
HR (1) HRP20150026T1 (https=)
IL (1) IL213032A (https=)
MX (1) MX2011006022A (https=)
PL (1) PL2370440T3 (https=)
PT (1) PT2370440E (https=)
RS (1) RS53777B1 (https=)
SI (1) SI2370440T1 (https=)
SM (1) SMT201500012B (https=)
WO (1) WO2010068581A1 (https=)
ZA (1) ZA201103397B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1781657T3 (pl) * 2004-02-14 2013-08-30 Glaxosmithkline Ip Dev Ltd Leki o aktywności wobec receptora HM74A
ES2401128T3 (es) 2005-08-10 2013-04-17 Glaxosmithkline Llc Derivados de xantina como agonistas selectivos de HM74A
EA201491749A1 (ru) * 2012-03-22 2015-01-30 ТРАНСТЕК ФАРМА, ЭлЭлСи Трис-(гидроксиметил)аминометановые соли низкомолекулярного агониста glp1r, их фармацевтические композиции и применение
CN121219290A (zh) 2023-02-27 2025-12-26 珊顿医药科技新加坡公司 化合物8-氯-3-戊基-3,7-二氢-1h-嘌呤-2,6-二酮的晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657327A (en) * 1970-06-01 1972-04-18 Upjohn Co Prostaglandin salts of tris(hydroxymethyl)aminomethane
US4647585A (en) 1984-11-08 1987-03-03 E. R. Squibb & Sons, Inc. Bicycloheptane substituted ethers
EP1237851A4 (en) * 1999-12-15 2004-06-23 Smithkline Beecham SALES OF I CIS / I-4-CYANO-4-3- (CYCLOPENTYLOXY) -4-METHOXYPHENYL] CYCLHEXAN-1-CARBONIC ACID
US20030013905A1 (en) 2002-06-10 2003-01-16 Huang Guishu Kris Salts of cis-4-cyano-4[3(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid
PL1781657T3 (pl) 2004-02-14 2013-08-30 Glaxosmithkline Ip Dev Ltd Leki o aktywności wobec receptora HM74A
GB0423568D0 (en) * 2004-10-22 2004-11-24 Smithkline Beecham Corp Novel compounds
US20090209561A1 (en) 2004-10-22 2009-08-20 Richard Jonathan Daniel Hatley Xanthine Derivatives with HM74A Receptor Activity
GB0516464D0 (en) * 2005-08-10 2005-09-14 Smithkline Beecham Corp Novel compounds
ES2401128T3 (es) 2005-08-10 2013-04-17 Glaxosmithkline Llc Derivados de xantina como agonistas selectivos de HM74A

Similar Documents

Publication Publication Date Title
JP2023546125A5 (https=)
JP2012511028A5 (https=)
NO20056056L (no) N-actyl nitrogenheterocykler som ligander av peroksisom-proliferatoraktiverte reseptorer
JP2011528362A5 (https=)
JP2016041701A5 (https=)
NO343371B1 (no) Nye forbindelser med DGAT1-aktivitet, farmasøytiske sammensetninger inneholdende slike og anvendelse derav
WO2006067224A3 (en) Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
EP1636205A1 (en) Pyridinyl carbamates as hormone-sensitive lipase inhibitors
JP2008521831A5 (https=)
CA2687927A1 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
NO20091045L (no) 3-Pyridinkarboksamid- og 2-pyrazinkarboksamid-derivatives som HDL.kolesterol-okende midler
WO2009056070A1 (en) Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application
JP2011508775A5 (https=)
JP2016500063A5 (https=)
WO2014025942A1 (en) Nmda receptor modulators and uses related thereto
JP2016513730A5 (https=)
EP2308562A3 (en) Azetidine ring compounds and drugs comprising the same
WO2005123718A3 (en) Benzimidazolone carboxylic acid derivatives
WO2013139341A1 (en) Gpr120 receptor modulators
HRP20150026T1 (hr) 8-klor-3-pentil-3,7-dihidro-1h-purin-2,6-dion 2-amino-2-(hidroksimetil)-1,3-propandiol anhidrat za lijeäśenje bolesti
RU2012113924A (ru) 5-(3,4-дихлорфенил)-n-(2-гидроксициклогексил)-6-(2,2,2-трифторэтокси)никотинамид и его соли в качестве средств, повышающих концентрацию лвп холестерина
IL220720A (en) Compounds whose molecule contains an oxazolo [4,5– a] pyrimidine ring and a carboxyl group, which can undergo astrification, for the treatment of wound-related syndromes and also for diabetic foot syndrome, as well as a process for their preparation
JP2023530786A5 (https=)
WO2005115384A3 (en) Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
JP2009543773A5 (https=)